Capital raising by cannabis companies is down 64% to $4 billion in year-to-date 2022 compared to 2021, Viridian Capital Advisors reported Wednesday. Total equity issuance has fallen 74.4% to about $1 billion, with total debt issuance down 48.
2% to about $2 billion. Public companies accounted for 74.5% of total financing year-to-date, down from 79.8% in 2021. The AdvisorShares Pure U.S. Cannabis ETF MSOS, +1.82% is down 52% in 2022 and the ETFMG Alternative Harvest ETF MJ, -1.36% has fallen 47.7%.
It's down from its.......highs?